A randomized trial of adjunct testosterone for cancer‐related muscle loss in men and women

• Egile Nagusiak: Traver J. Wright (Egilea), E. Lichar Dillon (Egilea), William J. Durham (Egilea), Albert Chamberlain (Egilea), Kathleen M. Randolph (Egilea), Christopher Danesi (Egilea), Astrid M. Horstman (Egilea), Charles R. Gilkison (Egilea), Maurice Willis (Egilea), Gwyn Richardson (Egilea), Sandra S. Hatch (Egilea), Daniel C. Jupiter (Egilea), Susan McCammon (Egilea), Randall J. Urban (Egilea), Melinda Sheffield‐Moore (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2018-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Cancer cachexia negatively impacts cancer‐related treatment options, quality of life, morbidity, and mortality, yet no established therapies exist. We investigated the anabolic properties of testosterone to limit the loss of body mass in late stage cancer patients undergoing stan...